Childrens Hospital of Pittsburg Childrens Hospital of Pittsburg
View Webcast with Flash Player

View webcast with Adobe Flash Player.
Click here to download


Preview
FAQ about UTI and VUR
FAQ about the VUR NIH Clinical Trial

Urinary Tract Infection and Vesicoureteral Reflux:

Are We Doing Enough or Too Much?
A Live Pediatric Grand Rounds CME Presentation.
September 13, 2007
8:00 AM EDT
(12:00 UTC)
From Children's Hospital of Pittsburgh, Pittsburgh, PA
Register

Urology: Urinary tract infections and vesicoureteral reflux are serious health problems affecting millions of people each year. In fact, they are the second most common type of infection in the body. Children who go undetected for urinary tract infections can suffer from far more severe conditions such as high blood pressure and bladder infections when they become adults. Children's Hospital of Pittsburgh of UPMC has performed more than two decades of research on Urinary Tract Infections and Vesicoureteral Reflux, and is now engaged in a nationwide study to determine the benefits of early diagnosis and treatment in babies. Join the nation's preeminent authorities on UTI and VUR – Alejandro Hoberman, MD, chief, General Academic Pediatrics, and Steven G. Docimo, MD, chief, Pediatric Urology – for the next in our series of live Webcasts that will analyze the importance and necessity of these critical methods and procedures.

Drs. Hoberman and Docimo will discuss previous studies conducted at Children's Hospital of Pittsburgh of UPMC examining the prevalence of urinary tract infection in young febrile children, accurate diagnostic criteria, adequate treatment and diagnostic imaging following an initial episode of urinary tract infection. They will also analyze the impact of vesicoureteral reflux and dysfuncional voiding, and address the management of children with vesicoureteral reflux, the role of antibiotics, surgery, and the management of dysfunctional elimination syndrome.

Finally, they will provide the results of a study designed to answer some basic questions about vesicoureteral reflux. The study is sponsored by National Institute of Diabetes, Digestive and Kidney Diseases (of the NIH) and is currently being conducted at 15 participating North American institutions.

Topics covered in Webcast:
  • Results from previous studies: prevalence and diagnosis of UTI
  • Treatment of UTI: oral vs. IV antimicrobials
  • Approach to follow-up diagnostic imaging
  • Antimicrobial resistance among urinary tract pathogens
  • Areas warranting further research — Management of VUR: NIDDK-RIVUR (Randomized Intervention for children with Vesicoureteral Reflux)
  • Dysfunctional elimination syndrome
  • Surgical management
  •  
Urology: Urinary tract infections and vesicoureteral reflux are serious health problems affecting millions of people each year. In fact, they are the second most common type of infection in the body. Children who go undetected for urinary tract infections can suffer from far more severe conditions such as high blood pressure and bladder infections when they become adults. Children's Hospital of Pittsburgh of UPMC has performed more than two decades of research on Urinary Tract Infections and Vesicoureteral Reflux, and is now engaged in a nationwide study to determine the benefits of early diagnosis and treatment in babies. Join the nation's preeminent authorities on UTI and VUR – Alejandro Hoberman, MD, chief, General Academic Pediatrics, and Steven G. Docimo, MD, chief, Pediatric Urology – for the next in our series of live Webcasts that will analyze the importance and necessity of these critical methods and procedures.

Drs. Hoberman and Docimo will discuss previous studies conducted at Children's Hospital of Pittsburgh of UPMC examining the prevalence of urinary tract infection in young febrile children, accurate diagnostic criteria, adequate treatment and diagnostic imaging following an initial episode of urinary tract infection. They will also analyze the impact of vesicoureteral reflux and dysfuncional voiding, and address the management of children with vesicoureteral reflux, the role of antibiotics, surgery, and the management of dysfunctional elimination syndrome.

Finally, they will provide the results of a study designed to answer some basic questions about vesicoureteral reflux. The study is sponsored by National Institute of Diabetes, Digestive and Kidney Diseases (of the NIH) and is currently being conducted at 15 participating North American institutions.

Topics covered in Webcast:
  • Results from previous studies: prevalence and diagnosis of UTI
  • Treatment of UTI: oral vs. IV antimicrobials
  • Approach to follow-up diagnostic imaging
  • Antimicrobial resistance among urinary tract pathogens
  • Areas warranting further research — Management of VUR: NIDDK-RIVUR (Randomized Intervention for children with Vesicoureteral Reflux)
  • Dysfunctional elimination syndrome
  • Surgical management

Presented By OR-Live
MDirect Access
View Previous Webcasts

 Webcast Links

  • View Preview in Real Player
  • About the Presenters
  • Rapid Learning Option
  • RIVUR Study – National site
  • View Previous Webcasts
  • Find Your Local Time
  • Register for CME Access

  Share

del.icio.us del.icio.us
Digg It! Digg It!

Event Site © OR-Live, Inc. 2014